N. Dereu

From Random Screening of Chemical Libraries to the Optimization of FPP-Competitive Inhibitors of Farnesyltransferase

P. Vrignaud, M. Bissery, J. Riou, 2001 .

Combination of the novel farnesyltransferase inhibitor RPR130401 and the geranylgeranyltransferase‐1 inhibitor GGTI‐298 disrupts MAP kinase activation and G1‐S transition in Ki‐Ras‐overexpressing transformed adrenocortical cells

S. Sebti, A. Hamilton, B. Maume, 1999, FEBS letters.

Structure-activity relationships of a series of anti-inflammatory benzisoselenazolones (BISAs)

M. Parnham, N. Dereu, S. Leyck, 1989, Agents and Actions.

Tricyclic series of heat shock protein 90 (Hsp90) inhibitors part I: discovery of tricyclic imidazo[4,5-c]pyridines as potent inhibitors of the Hsp90 molecular chaperone.

Paul Ferrari, Patrick Mailliet, Hervé Minoux, 2011, Journal of medicinal chemistry.

INTERACTION OF EBSELEN WITH HEPATIC ARACHIDONATE METABOLISM IN VIVO

A. Wendel, G. Tiegs, N. Dereu, 1988 .

Omega-[(omega-arylalkyl)aryl]alkanoic acids: a new class of specific LTA4 hydrolase inhibitors.

R. Labaudinière, M. Parnham, P. Kuhl, 1992, Journal of medicinal chemistry.

Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells.

E. De Clercq, R. Pauwels, A. Bousseau, 1994, Proceedings of the National Academy of Sciences of the United States of America.